Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
about
Protective roles of NF-kB for chromium (VI)-induced cytotoxicity is revealed by expression of IkB kinase-B mutantIAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition.XIAP: cell death regulation meets copper homeostasisA novel role for XIAP in copper homeostasis through regulation of MURR1VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activationXIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative diseaseUbiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell deathFGD2, a CDC42-specific exchange factor expressed by antigen-presenting cells, localizes to early endosomes and active membrane rufflesThe anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sitesXIAP regulates cytosol-specific innate immunity to Listeria infectionXIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 DimerizationX-linked lymphoproliferative syndromes: brothers or distant cousins?ILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosisNeurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell deathDoes antigen masking by ubiquitin chains protect from the development of autoimmune diseases?Jun kinase delays caspase-9 activation by interaction with the apoptosomeIAP regulation of metastasis.Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiencyAfrican swine fever virus IAP-like protein induces the activation of nuclear factor kappa BThe IAP proteins: caspase inhibitors and beyond.Survivin and IAP proteins in cell-death mechanismsTranslational upregulation of the X-linked inhibitor of apoptosis.Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.IAP-targeted therapies for cancer.XIAP mediates NOD signaling via interaction with RIP2XIAP as a ubiquitin ligase in cellular signaling.A mutational analysis of the baculovirus inhibitor of apoptosis Op-IAP.X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.XIAP upregulates expression of HIF target genes by targeting HIF1α for Lys63-linked polyubiquitination.Distinct role of calmodulin and calmodulin-dependent protein kinase-II in lipopolysaccharide and tumor necrosis factor-alpha-mediated suppression of apoptosis and antiapoptotic c-IAP2 gene expression in human monocytic cells.Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis.Inhibiting apoptosis in mammalian cell culture using the caspase inhibitor XIAP and deletion mutants.Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival.Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis.
P2860
Q23912833-86E97332-390B-482C-BC1C-4AB09CE44C53Q24292370-2215DC4B-DEB8-44DC-AFFA-71A0A4FA17D7Q24300814-B8E83858-C626-4376-B117-88BA5A51E414Q24302274-5B4A7A35-0CE4-4EFC-ADFA-464DA5E54644Q24304221-4D8004CA-E827-4EC5-8665-3CD67DF258C8Q24610800-983F3CB7-2DE7-422E-ADA7-FB989918F92BQ24630370-6CFADB69-9B8A-4929-9FE0-51F5BA03810CQ24652635-09AA794B-93F2-4C6A-8BD8-161B291175E0Q24673550-37B970FD-E8AB-4A0B-80FA-045BFA43116CQ27318530-579D5A47-F92F-4624-81E7-AB00EE0A9355Q27645534-7ACB7720-7235-4704-AADD-04E0C42522CFQ27690253-9AECF5A4-6153-4512-B1D5-1E1A9800A845Q28202543-82FA1229-9C2D-4D27-A8DB-D2F67E6F7522Q28215693-698E9C5A-8DB0-4692-881E-462E2F7A0FCEQ28387136-7C14D176-C391-4235-A6C5-0C04AE694D93Q28580043-87882C04-DF5F-481B-91F3-1F5E3674081CQ33638504-5BA811F0-39C1-4DD9-A7F0-49B26B8B39A0Q34242492-02F020E4-F95E-47B5-81CF-063EBF779AF1Q34336439-CC829673-3D31-490C-84E1-5BA72A6D3FDAQ34467672-ECCA9373-0936-4E91-86F0-458D1B217337Q35414780-DE21F3FC-BA90-4185-96A1-D628B50C414BQ35700319-76AC8E57-3490-424B-B766-00E5A253E781Q36274969-95ABFA3A-8A5E-4331-91A2-CF6B636132FEQ36965134-83EAFFDC-D108-415A-810F-153A119DA359Q37302745-CF2B1039-551B-41AF-8510-75878CCE8552Q37321233-AC32FD66-BA02-43C9-85CC-F5B3395C6B20Q37546803-841748F4-907B-43D9-80CC-C9D59B177B9EQ38330501-FE5939B2-9BC9-4DC5-992B-4445D5C1D72CQ38367445-4A74777F-AEBA-4332-A9E3-BDB8935CCE27Q38699817-8E9A4DDE-DAB2-4C57-B729-E3F950BC806CQ40375014-B0057CBB-1847-4495-934E-AF211FA2AFE7Q40602863-8ADC50EB-A10C-49E1-9EE0-3F67E5C4229EQ40755337-6D028427-8105-4D7E-9AB2-857F50BC366BQ40870782-7C9C957A-13D5-4FE4-953B-A03DDEE99584Q43181903-770607E2-99E4-4470-942B-0D0F23A5DB39Q43505476-B3FE36A6-0BC8-4770-9938-07105598A353Q44104444-78777ED1-0821-4D58-9E29-80F491BB4DB9
P2860
Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
@en
Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
@nl
type
label
Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
@en
Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
@nl
prefLabel
Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
@en
Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
@nl
P2093
P2860
P356
P1476
Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.
@en
P2093
B W Richter
C B Thompson
C S Duckett
R J Ulevitch
P2860
P304
P356
10.1073/PNAS.95.11.6015
P407
P577
1998-05-01T00:00:00Z